740 Y-P: PI 3-Kinase Activator for Vesicular and Neuronal Re
2026-06-25
740 Y-P stands out as a potent, cell-permeable PI 3-kinase activator ideal for dissecting the PI3K/AKT pathway in vesicular trafficking and neuronal survival assays. Protocol flexibility and robust activation underpin its utility for troubleshooting complex apoptosis and cell stress models.
Octenidine Dihydrochloride: Mechanistic Insights and Researc
2026-06-25
Explore the molecular mechanism, solubility challenges, and optimal research applications of Octenidine dihydrochloride, an advanced antiseptic research compound. This article uniquely connects structure-activity relationships to practical assay design and laboratory workflows.
Bufuralol Hydrochloride: Precision β-Adrenergic Modulation i
2026-06-24
Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist, is pivotal for advanced cardiovascular pharmacology research. This article uniquely explores its integration into human intestinal organoid-based pharmacokinetic assays, revealing novel insights beyond traditional models.
Degarelix Acetate in Prostate Cancer: Rapid Androgen Depriva
2026-06-23
The reference study demonstrates that degarelix acetate, a third-generation GnRH antagonist, enables rapid medical castration and prostate-specific antigen suppression in advanced prostate cancer, avoiding the testosterone surge seen with GnRH agonists. These findings inform both clinical treatment strategies and mechanistic research into androgen deprivation, with implications for translating hormonal modulation insights to other cancer models.
CUDC-907: Dual PI3K and HDAC Inhibition for Cancer Research
2026-06-23
CUDC-907 enables targeted dual inhibition of PI3K and HDAC pathways in established cancer cell models, supporting mechanistic studies of signaling, cell cycle arrest, and apoptosis. It is intended strictly for in vitro research in controlled laboratory workflows and is not suitable for diagnostic, therapeutic, or clinical applications.
CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E
2026-06-22
The reference study uncovers CLCC1 as an essential host mediator of membrane fusion during herpesvirus nuclear egress, resolving a long-standing gap in the understanding of HSV-1 replication. This mechanistic insight into viral-host interplay informs both fundamental virology and translational research in antiviral immunotherapy.
EZH2 Maintains Epithelial Identity in Breast Carcinoma Cells
2026-06-22
Gallardo et al. reveal that EZH2, the catalytic subunit of PRC2, represses mesenchymal gene expression to maintain the epithelial state in breast carcinoma cells. This finding clarifies a conserved mechanism of epigenetic regulation during epithelial-mesenchymal transitions in cancer, with implications for targeted inhibition strategies.
Azilsartan Medoxomil Monopotassium Outperforms in Hypertensi
2026-06-21
A comprehensive network meta-analysis demonstrates that azilsartan medoxomil (TAK 491) achieves superior systolic and diastolic blood pressure reductions compared to other antihypertensive agents in mild-to-moderate hypertension. The study's robust design and ranking methodology provide strong support for its use in essential hypertension treatment research and blood pressure regulation studies.
4-Hydroxytamoxifen: Technical Guidance for Cancer Research
2026-06-20
4-Hydroxytamoxifen is a high-purity estrogen receptor modulator designed for DMSO-based workflows in breast and prostate cancer research, as well as cardiac myocyte calcium handling studies. It should not be used in protocols requiring aqueous or ethanol solubility, and proper storage and preparation are essential for reproducibility.
Intravesical p21 mRNA–LNPs: Advancing Bladder Cancer Therapy
2026-06-19
This study introduces a localized, non-viral therapeutic approach for bladder cancer using p21 mRNA–loaded lipid nanoparticles (LNPs) delivered intravesically. The strategy restores tumor suppressor function, significantly suppresses tumor growth, and highlights the translational potential of mRNA–LNP platforms for urologic malignancies.
O-GlcNAcylation Drives Wnt-Induced Bone Formation via Glycol
2026-06-19
The reference study uncovers how O-GlcNAcylation regulates Wnt-stimulated bone formation by rewiring aerobic glycolysis in osteoblasts. This mechanistic insight highlights the significance of metabolic modulation in osteogenesis and provides a foundation for new therapeutic strategies targeting bone disorders.
Acetylcysteine in Tumor Microenvironment: Mechanisms & Model
2026-06-18
Explore acetylcysteine's unique role in tumor microenvironment modeling and oxidative stress pathway modulation. This in-depth analysis uncovers new mechanistic insights and protocol considerations for advanced cancer and disease research.
BMS 309403: Advanced Insights into FABP4 Inhibition for Athe
2026-06-18
Explore the scientific depth and translational utility of BMS 309403, a potent FABP4 inhibitor, in atherosclerosis and metabolic disease research. Unique mechanistic perspectives and protocol guidance set this comprehensive review apart.
EdU Imaging Kits (Cy5): Reliable S-Phase Cell Proliferation
2026-06-17
This article translates real laboratory scenarios into practical, evidence-based guidance on deploying EdU Imaging Kits (Cy5) (SKU K1076) for precise, reproducible S-phase DNA synthesis measurement. Emphasizing workflow safety, data quality, and compatibility, it synthesizes current literature and expert practice to help researchers optimize cell proliferation, cytotoxicity, and genotoxicity studies using click chemistry-based EdU detection.
FPH1 (BRD-6125): Enhancing Functional Proliferation of Hepat
2026-06-17
FPH1 (BRD-6125) is a small molecule that enables robust, donor-independent proliferation of primary human hepatocytes in vitro. It increases albumin secretion, elevates CYP3A4 enzyme expression, and supports functional maturation during iPS cell-to-hepatocyte differentiation. This article details its mechanism, benchmarks, and practical integration for research and cell therapy workflows.
460 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page